Fecal microbiota transplantation may improve immunotherapy-related colitis

Дата публикации: 15-09-2026 16:40:05

Targeting the gut microbiome with fecal microbiota transplantation (FMT) may help cancer patients with immunotherapy-related colitis avoid the need for steroids and other immunosuppressive treatments, according to researchers at The University of Texas MD Anderson Cancer Center.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	B cells may help predict risk of colitis from immunotherapy	0	5.92	18-09-2026
2	Fecal microbial signatures show promise for colorectal and pancreatic cancer assessment	0	5.44	16-09-2026
3	Кишечные бактерии предскажут эффективность иммунотерапии только в сообществе	5	7	11-06-2026
4	Why colorectal cancer breaks the immune system’s rules	0	8.01	06-02-2026
5	Fasting primes gut microbiome to improve intestinal recovery after radiation treatment	5	7	10-07-2026
6	Novel biomarker research offers new hope in the fight against colorectal cancer	7	8	06-07-2026
7	Scientists turn probiotic bacteria into tiny drug factories for pancreatic cancer	0	10.79	19-08-2026
8	New, improved method to find and isolate the strongest cancer-fighting immune cells	7	8	08-07-2026
9	Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery	0	5	06-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 9.48. Источник: medicalxpress.com.